S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
Vertex Pharmaceuticals Incorporated (VRTX)
Chart Events
Performance Outlook
| Previous Close | 255.45 |
| Open | 256.61 |
| Bid | 247.38 x 1000 |
| Ask | 258.87 x 1300 |
| Day's Range | 252.51 - 259.10 |
| 52 Week Range | 176.36 - 292.75 |
| Volume | |
| Avg. Volume | 1,656,896 |
| Market Cap | 65.747B |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | 31.01 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investopedia
Industries That Can Thrive During Recessions
With the COVID-19 crisis sending the U.S. economy in a recession, we're looking at what companies managed to thrive during the last recession for guidance.
- Investor's Business Daily
Vertex Pharmaceuticals Receives Composite Rating Upgrade
On Tuesday, Vertex Pharmaceuticals got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. Keep an eye out to see if VRTX stock sees more buying action from institutional investors. The new Composite score means the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
- Motley Fool
Have $2,000? 2 Market Crash-Ready Stocks to Buy
You may be spending a little more time than you'd like these days thinking about a future market crash. But instead of letting the recent stock-market decline scare us, we should let it help us: Let's use it as a reminder that market corrections and crashes will happen.
